Shopping Cart
Remove All
Your shopping cart is currently empty
K1586 is an effective guanidine derivative targeting Chk1. It enhances the degradation of Chk1, sensitizing colorectal cancer cells to ionizing radiation, and demonstrates anticancer activity.
| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | K1586 is an effective guanidine derivative targeting Chk1. It enhances the degradation of Chk1, sensitizing colorectal cancer cells to ionizing radiation, and demonstrates anticancer activity. |
| In vitro | K1586 reduces cell proliferation in a dose-dependent manner when applied at concentrations of 0.001-100 μM over 72 hours. At concentrations of 10-20 μM for 24 hours, it increases the relative length of the S phase and significantly extends the duration of the G2/M phase. Additionally, K1586 decreases Chk1 protein levels in a time-dependent manner at 10 μM over a 12-hour period. |
| Formula | C18H18ClN3OS |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.